Urology · Bend, OR
NPI
1316161680
Since 2007
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2090 NE Wyatt Ct, Suite 101
Bend, OR, 97701
Phone (541) 382-6447
Groups this clinician bills Medicare through
Medicare paid, 2024
$285K
20,721 services
Medicare patients, 2024
1,334
Average age 76
Drug cost, 2024
$840K
3,869 prescriptions
Company payments, 2025
$621
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meredith R Baker was code J1071 (injection, testosterone cypionate, 1 mg), 12,010 times for 19 patients. In total Meredith R Baker billed 20,721 services in 97 codes, and Medicare paid $285K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 12,010 | 19 | $0.02 | $236 |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 2,897 | 44 | $2.16 | $6,266 |
| 99214 Office E&M - Established | Office | 712 | 535 | $92.69 | $66K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 706 | 591 | $12.80 | $9,038 |
| 99213 Office E&M - Established | Office | 693 | 584 | $63.31 | $44K |
| 81002 Clinical Chemistry | Office | 630 | 467 | $3.39 | $2,137 |
| 81015 Clinical Chemistry | Office | 630 | 471 | $2.96 | $1,868 |
| 99204 Office E&M - New | Office | 208 | 208 | $112.69 | $23K |
| 52000 Cystourethroscopy | Facility | 202 | 184 | $61.89 | $13K |
| 36415 Venipuncture Blood Collection | Office | 169 | 123 | $8.60 | $1,454 |
| 84153 Clinical Chemistry | Office | 123 | 81 | $18.02 | $2,216 |
| 51720 Chemotherapy Administration | Office | 117 | 46 | $67.57 | $7,906 |
| 51798 Ultrasound - Nonspecific | Office | 107 | 101 | $8.78 | $939 |
| 96372 Injection Administration | Office | 103 | 20 | $10.53 | $1,085 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 99 | 15 | $135.06 | $13K |
By year: 2022 $253K for 9,833 services; 2023 $265K for 15,941 services; 2024 $285K for 20,721 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 630 | 467 | $3.39 | $2,137 |
| 81015 Clinical Chemistry | 630 | 471 | $2.96 | $1,868 |
| 36415 Venipuncture Blood Collection | 169 | 123 | $8.60 | $1,454 |
| 84153 Clinical Chemistry | 123 | 81 | $18.02 | $2,216 |
| 81001 Clinical Chemistry | 69 | 52 | $3.08 | $213 |
| 82565 Clinical Chemistry | 31 | 31 | $5.02 | $156 |
| 82570 Clinical Chemistry | 28 | 28 | $4.94 | $138 |
| 82043 Clinical Chemistry | 28 | 28 | $5.50 | $154 |
| 84403 Clinical Chemistry | 23 | 14 | $25.29 | $582 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 15 | 15 | $17.66 | $265 |
Medicare prescription drug claims, 2024
In 2024, the drug Meredith R Baker prescribed most often to Medicare patients was Finasteride, with 682 prescriptions and refills. In total Meredith R Baker wrote 3,869 Medicare prescriptions that cost $840K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 682 | 1,883 | 206 | $12K |
| Estradiol Generic | 484 | 2,397 | 330 | $35K |
| Tamsulosin Hcl Generic | 437 | 1,193 | 146 | $9,415 |
| Myrbetriq Mirabegron | 358 | 938 | 134 | $406K |
| Trospium Chloride Generic | 328 | 630 | 102 | $23K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 281 | 821 | 97 | $7,805 |
| Gemtesa Vibegron | 263 | 572 | 81 | $260K |
| Cephalexin Generic | 151 | 179 | 124 | $772 |
| Oxybutynin Chloride Generic | 59 | 126 | 21 | $1,147 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 59 | 59 | 49 | $674 |
| Fosfomycin Tromethamine Generic | 46 | 46 | 19 | $2,769 |
| Ciprofloxacin Hcl Generic | 43 | 43 | 37 | $111 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 43 | 124 | 14 | $3,665 |
| Solifenacin Succinate Generic | 41 | 121 | 14 | $1,106 |
| Silodosin Generic | 38 | 58 | Under 11 | $4,197 |
Brand drugs: - claims; generic drugs: 3,164 claims; opioid claims: 38.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meredith R Baker $621 ($621 in general payments such as food, travel and fees) from 11 companies. The largest payer was Sumitomo Pharma America, Inc. with $191.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 4 | $191 |
| Valencia Technologies Corporation | 6 | $165 |
| Abbvie Inc. ABBV | 3 | $63.29 |
| Coloplast Corp | 1 | $42.03 |
| Janssen Biotech, Inc. JNJ | 2 | $41.56 |
| Urogen Pharma, Inc. URGN | 1 | $24 |
| Accord Healthcare, Inc. | 1 | $22.73 |
| Calyxo, Inc. | 1 | $20.23 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $18.48 |
| Procept Biorobotics Corporation PRCT | 1 | $16.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.